This new study looks into the DNA repair profile as a predictor for the clinical outcome of patients receiving trabectedin treatment (also called yondelis, ET-743):
http://www.ncbi.nlm.nih.gov/pubmed/21376569
This new study looks into the DNA repair profile as a predictor for the clinical outcome of patients receiving trabectedin treatment (also called yondelis, ET-743):
http://www.ncbi.nlm.nih.gov/pubmed/21376569